| 1 |
35498227 | Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators. | 2022 Mar |
1 |
| 2 |
33859430 | Inhibition of the IL-17A axis in adipocytes suppresses diet-induced obesity and metabolic disorders in mice. | 2021 Apr |
1 |
| 3 |
29545199 | Imiquimod-Induced Psoriasis-Like Skin Lesions Do Not Accelerate Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. | 2018 Jun |
1 |
| 4 |
26879387 | Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice. | 2016 May |
3 |
| 5 |
27658195 | Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A. | 2016 Sep |
1 |
| 6 |
25819229 | Digoxin ameliorates autoimmune arthritis via suppression of Th17 differentiation. | 2015 May |
2 |
| 7 |
23813495 | Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver. | 2014 Jan |
1 |
| 8 |
25234817 | Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm. | 2014 Nov |
2 |
| 9 |
21733845 | Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production. | 2011 Sep 9 |
4 |